Taking benzodiazepines during pregnancy carries real risks for the baby, particularly heart defects and withdrawal symptoms after birth. About 1 in 50 pregnant women are prescribed benzodiazepines, but most clinical guidelines recommend tapering off them when possible and switching to safer alternatives.
That said, stopping abruptly can be dangerous too, both for you and the pregnancy. The answer isn’t a simple yes or no. It depends on when in the pregnancy you are, what you’re taking, and how severe your anxiety or panic disorder is.
Risks in the First Trimester
The first trimester is when a baby’s organs are forming, which makes it the most sensitive window for any medication exposure. A large population-based study in South Korea found that first-trimester benzodiazepine use was associated with a 9% higher risk of birth defects overall and a 15% higher risk of heart defects specifically. Those numbers are modest in absolute terms, but they’re statistically significant across large populations.
Older studies raised concerns about cleft lip and palate, and that fear still circulates widely. More recent research, including the South Korean study, has not confirmed that link. The heart defect risk, however, has held up more consistently across newer data.
Risks in the Third Trimester
Late-pregnancy use creates a different set of problems. Benzodiazepines cross the placenta rapidly, meaning the baby is exposed to the same sedating effects you are. When the baby is born and that supply is suddenly cut off, two things can happen.
The first is sometimes called “floppy infant syndrome.” Babies born to mothers taking benzodiazepines in the final weeks of pregnancy can have unusually low muscle tone, weak reflexes, and difficulty breathing or feeding. In documented cases involving twins exposed to diazepam in the last month of pregnancy, neurological function returned to normal within about two weeks as the drug cleared the babies’ systems.
The second concern is neonatal withdrawal. Unlike opioid withdrawal, which typically shows up within the first 48 hours of life, benzodiazepine withdrawal in newborns can be delayed. Depending on the specific drug, symptoms may not appear for 7 to 21 days after birth. This delay can catch parents off guard. Symptoms include high-pitched crying, tremors, irritability, poor feeding, vomiting, diarrhea, and in some cases seizures. The baby may also show changes in heart rate, breathing, and body temperature. Withdrawal symptoms can persist for up to four weeks.
Potential Effects on Child Development
A systematic review of studies on children exposed to benzodiazepines before birth found some evidence of long-term developmental effects, including higher rates of attention difficulties and traits associated with ADHD, weaker gross motor skills, lower academic performance, and a greater tendency toward anxiety and internalizing behaviors. These findings are concerning, but the researchers noted that results across studies were inconsistent. It’s difficult to separate the effects of the drug from the effects of the mother’s underlying anxiety or other factors. Whether these developmental differences persist into later childhood remains unclear.
Why You Shouldn’t Stop Abruptly
If you’re already taking benzodiazepines and discover you’re pregnant, the instinct to stop immediately is understandable but potentially harmful. Abrupt withdrawal can cause seizures, severe rebound anxiety, and physiological stress that may be worse for the pregnancy than a carefully managed taper.
Clinical guidelines from the American Society of Addiction Medicine recommend a structured approach depending on where you are in pregnancy. In the first trimester, if your provider plans to switch you to a different medication (such as an SSRI for anxiety), the new medication should be started early because it takes six to eight weeks to reach full effectiveness. You’d continue the benzodiazepine at a reduced level during that transition rather than going without treatment. By the third trimester, the goal shifts to reaching the lowest possible dose to minimize the risk of neonatal withdrawal at delivery.
Safer Alternatives for Anxiety
For mild to moderate anxiety, non-drug approaches are considered the safest first option during pregnancy. Cognitive behavioral therapy (CBT) has the strongest evidence base and is recommended by multiple guidelines as a frontline treatment. Guided self-help programs and structured relaxation techniques are also options, though the research behind them is thinner.
When anxiety is severe enough to require medication, SSRIs are generally considered a safer pharmacological choice than benzodiazepines during pregnancy. They aren’t risk-free, but decades of data on their use in pregnancy provide a clearer safety picture than what exists for benzodiazepines. The trade-off is that SSRIs take weeks to work, which is why planning the switch early matters so much. For women with severe or treatment-resistant anxiety, specialist mental health services can help weigh the risks of continued benzodiazepine use against the risks of untreated illness.
What This Means Practically
If you’re planning a pregnancy and currently take benzodiazepines, the ideal scenario is to taper off before conceiving, with your provider’s guidance. That gives you time to transition to a safer medication or therapy without the pressure of an active pregnancy.
If you’re already pregnant, the calculus is more nuanced. Untreated severe anxiety and panic disorder carry their own pregnancy risks, including preterm birth and low birth weight. The goal is never to leave you without treatment. It’s to find the approach that protects both you and the baby with the least overall risk. The specific plan depends on your dose, how long you’ve been taking the medication, the severity of your condition, and how far along you are.